Medplus Health Services Ltd.
Fundamentals
- Market cap
- ₹10,031 cr
- P/E
- 45.67×
- ROE
- 8.64%
- Debt / equity
- 0.00
- 52-week range
- 732.00 — 1022.20
Company snapshot
Medplus Health Services Ltd.
Pharmaceuticals
₹8,661 cr
P/E 41.15×
Latest quarter · Jun 2026
Sales₹1,880 cr
Net profit₹33 cr
Op. margin+7.1%
EPS₹2.76
Strength & growth
Debt / equity0.00×
Current ratio2.81×
The timeline — 5 notes on Medplus Health Services Ltd.
July 2026
- 28 Jul 26 · 3:39 PM IST Brief Brief · Credit · Mid cap
Medplus sees another 4.08% of equity pledged; total with Catalyst tops 17%
Catalyst Trusteeship created a pledge over 4.9 million shares on June 24. The pledgor is unnamed while promoters already have 60.7% of their holding pledged.
- 21 Jul 26 · 7:10 PM IST Brief Brief · Mid cap
MedPlus steps beyond pharmacy with ₹155 cr food-and-wellness bets
The pharmacy chain diversifies into cold-press oils and concierge health, but the ₹155 cr spend is just 1.7% of revenue.
May 2026
- 21 May 26 · 5:12 PM IST Brief Brief · Earnings · Mid cap
MedPlus targets 800 new stores in FY27, private label margins recover
Management guides same-store sales growth of 9-10% annually and zero external debt. Private label contribution to rise 20-30 bps per quarter.
- 20 May 26 · 9:18 PM IST Brief Brief · Earnings · Mid cap
MedPlus profit jumps 46% as pharmacy margins expand
Net profit hit ₹2.20 billion on 12% revenue growth for FY26. The board also shuffled its top ranks.
- 20 May 26 · 9:07 PM IST Brief Brief · Earnings · Mid cap
MedPlus profit jumps 46% to ₹2,196.1 mn, revenue up 12% to ₹68,924.6 mn
Annual results show strong margin expansion; profit growth outpaces revenue by nearly 4x.